Brian E. Leonard - Publications

Affiliations: 
University College Galway, Galway, County Galway, Ireland 

337 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Demin KA, Lakstygal AM, Volgin AD, de Abreu MS, Genario R, Alpyshov ET, Serikuly N, Wang D, Wang J, Yan D, Wang M, Yang L, Hu G, Bytov M, Zabegalov KA, ... ... Leonard BE, et al. Cross-species analyses of intra-species behavioral differences in mammals and fish. Neuroscience. PMID 31931109 DOI: 10.1016/j.neuroscience.2019.12.035  0.36
2017 Ma L, Demin KA, Kolesnikova TO, Kharsko SL, Zhu X, Yuan X, Song C, Meshalkina DA, Leonard BE, Tian L, Kalueff AV. Animal inflammation-based models of depression and their application to drug discovery. Expert Opinion On Drug Discovery. 1-15. PMID 28816544 DOI: 10.1080/17460441.2017.1362385  0.36
2015 Leonard BE. Pain, Depression and Inflammation: Are Interconnected Causative Factors Involved? Modern Trends in Pharmacopsychiatry. 30: 22-35. PMID 26437055 DOI: 10.1159/000435930  1
2015 Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 26111720 DOI: 10.1016/j.pnpbp.2015.06.008  1
2014 Leonard BE. Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48: 261-7. PMID 24189118 DOI: 10.1016/j.pnpbp.2013.10.018  1
2013 Leonard BE. Inflammation as the cause of the metabolic syndrome in depression. Modern Trends in Pharmacopsychiatry. 28: 117-26. PMID 25224895 DOI: 10.1159/000343974  1
2013 Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology (Oxford, England). 27: 967-71. PMID 24067791 DOI: 10.1177/0269881113503509  1
2013 Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 334-85. PMID 23879318 DOI: 10.3109/15622975.2013.804195  1
2013 Halaris A, Leonard BE. Inflammation in psychiatry Inflammation in Psychiatry. 28: 1-208. DOI: 10.1159/isbn.9783318023114  1
2013 Baldwin DS, Leonard BE. Anxiety disorders Anxiety Disorders. 29: 1-183. DOI: 10.1159/isbn.978-3-318-02464-7  1
2012 Loonen AJ, Leonard BE, van Praag HM. Little hope for further innovations in psychopharmacology? Human Psychopharmacology. 27: 437-9. PMID 22996615 DOI: 10.1002/hup.2252  1
2012 Maes M, Berk M, Goehler L, Song C, Anderson G, GaÅ‚ecki P, Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. Bmc Medicine. 10: 66. PMID 22747645 DOI: 10.1186/1741-7015-10-66  1
2012 Leonard BE, Schwarz M, Myint AM. The metabolic syndrome in schizophrenia: is inflammation a contributing cause? Journal of Psychopharmacology (Oxford, England). 26: 33-41. PMID 22472311 DOI: 10.1177/0269881111431622  1
2012 Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neuroscience and Biobehavioral Reviews. 36: 764-785. PMID 22197082 DOI: 10.1016/j.neubiorev.2011.12.005  1
2012 Tang SW, Helmeste D, Leonard B. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review World Journal of Biological Psychiatry. 13: 402-412. PMID 22175526 DOI: 10.3109/15622975.2011.639800  1
2012 Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. European Archives of Psychiatry and Clinical Neuroscience. 262: 13-22. PMID 22083391 DOI: 10.1007/s00406-011-0274-7  1
2012 Edwards JG, Leonard BE, Hindmarch I, Curran S, Devane L. Human Psychopharmacology: The first twenty-five years Human Psychopharmacology. 27: 1-3. DOI: 10.1002/hup.1277  1
2012 Navrátilová M, Jarkovský J, Tůmová J, Hamrová M, Sobotka L, Leonard B. Relationship of the blood pressure and nutritional state of the patients with anorexia nervosa and bulimia nervosa: The study of 117 patients in the 5 years study Malnutrition: Risk Factors, Health Effects and Prevention. 119-142.  1
2012 Navrátilová M, Jarkovský J, Češková E, Vašků A, Leonard B, Sobotka L. Influence of nutritional support on nutritional and mental status in dementia patients with Alzheimer's disease: Comparative and intervention study Malnutrition: Risk Factors, Health Effects and Prevention. 101-118.  1
2011 Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 261: 207-45. PMID 22033583 DOI: 10.1007/s00406-011-0259-6  1
2011 Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, Leonard B, Lorig K, Loureiro MI, van der Meer JW, Schnabel P, Smith R, van Weel C, Smid H. How should we define health? Bmj (Clinical Research Ed.). 343: d4163. PMID 21791490 DOI: 10.1136/bmj.d4163  1
2011 Myint AM, Schwarz MJ, Verkerk R, Mueller HH, Zach J, Scharpé S, Steinbusch HW, Leonard BE, Kim YK. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Brain, Behavior, and Immunity. 25: 1576-81. PMID 21620952 DOI: 10.1016/j.bbi.2011.05.005  1
2011 Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 659-63. PMID 21376099 DOI: 10.1016/j.pnpbp.2011.02.019  1
2011 Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 702-21. PMID 21185346 DOI: 10.1016/j.pnpbp.2010.12.017  1
2011 Debnath M, Doyle KM, Langan C, McDonald C, Leonard B, Cannon DM. Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders Translational Neuroscience. 2: 121-137. DOI: 10.2478/s13380-011-0019-0  1
2011 Myint AM, Schwarz MJ, Mueller N, Leonard BE. Immune-tryptophan pathway interaction - Possible pathophysiological role in major depressive disorder European Psychiatric Review. 4: 35-40.  1
2010 Leonard BE. The concept of depression as a dysfunction of the immune system. Current Immunology Reviews. 6: 205-212. PMID 21170282 DOI: 10.2174/157339510791823835  1
2010 Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. The British Journal of Psychiatry : the Journal of Mental Science. 197: 372-7. PMID 21037214 DOI: 10.1192/bjp.bp.109.076430  1
2010 Leonard B, Taylor D. Review: Escitalopram-translating molecular properties into clinical benefit: Reviewing the evidence in major depression Journal of Psychopharmacology. 24: 1143-1152. PMID 20147575 DOI: 10.1177/0269881109349835  1
2010 Cryan JF, Leonard BE. Depression: From psychopathology to pharmacotherapy Depression: From Psychopathology to Pharmacotherapy. 27: 1-274. DOI: 10.1159/isbn.978-3-8055-9606-0  1
2010 Cryan JF, Leonard BE. Modern Trends in Pharmacopsychiatry: Preface Modern Trends in Pharmacopsychiatry. 27: VII-VIII. DOI: 10.1159/000320280  1
2010 Tang SW, Helmeste DM, Leonard BE. Antidepressant compounds: A critical review Depression: From Psychopathology to Pharmacotherapy. 27: 1-19. DOI: 10.1159/000319425  1
2010 Song C, Leonard BE. Depression and Stress, Role of n-3 and n-6 Fatty Acids Encyclopedia of Stress. 754-760. DOI: 10.1016/B978-012373947-6.00685-1  1
2010 Leonard BE, Song C. Cytokines, Stress, and Depression Encyclopedia of Stress. 705-711. DOI: 10.1016/B978-012373947-6.00111-2  1
2009 Leonard BE, Myint AM. Immune dysfunction, depression and neurodegeneration. Acta Neuropsychiatrica. 21: 45-6. PMID 25384869 DOI: 10.1017/S0924270800032713  1
2009 Song C, Halbreich U, Han C, Leonard BE, Luo H. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry. 42: 182-8. PMID 19724980 DOI: 10.1055/s-0029-1202263  1
2009 Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Neuropsychobiology. 59: 123-9. PMID 19390223 DOI: 10.1159/000213565  1
2009 Leonard BE, Myint A. The psychoneuroimmunology of depression. Human Psychopharmacology. 24: 165-75. PMID 19212943 DOI: 10.1002/hup.1011  1
2009 Myint AM, Schwarz MJ, Steinbusch HW, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease. 24: 55-68. PMID 19067144 DOI: 10.1007/s11011-008-9114-5  1
2009 Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, ... ... Leonard B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte: Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares Revista De Psiquiatria Clinica. 36: 58-76. DOI: 10.1590/S0101-60832009000800002  1
2009 Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, ... ... Leonard B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior Revista De Psiquiatria Clinica. 36: 17-57. DOI: 10.1590/S0101-60832009000800001  1
2009 Leonard BE. Metabolic syndrome and schizophrenia: Is inflammation the cause? Modern Trends in Pharmacopsychiatry. 26: 1-11. DOI: 10.1159/000189771  1
2008 Van den Hove DL, Blanco CE, Scheepens A, Desbonnet L, Myint AM, Leonard BE, Prickaerts J, Steinbusch HW. Prenatal maternal paroxetine treatment and neonatal mortality in the rat: a preliminary study. Neonatology. 93: 52-5. PMID 17652957 DOI: 10.1159/000106433  1
2008 Grunze H, Baghai TC, Barrett B, Goodwin G, Markowitz JC, Knapp M, Leonard BE, Sartorius N. Antidepressant medications and other treatments of depressive disorders: A CINP Task Force report - A reply to Ban International Journal of Neuropsychopharmacology. 11: 587-589. DOI: 10.1017/S146114570800881X  1
2008 Baghai TC, Grunze H, Goodwin G, Leonard BE, Markowitz JC, Sartorius N. Antidepressant medications and other treatments of depressive disorders: A CINP Task Force report - A reply to Belmaker International Journal of Neuropsychopharmacology. 11: 579-582. DOI: 10.1017/S1461145708008808  1
2008 Leonard BE. How important is psychoneuroimmunology? Salud Mental. 31: 83-85.  1
2008 Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Möller HJ, Kasper S, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, ... ... Leonard B, et al. Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP) | Biologische behandlung unipolarer depressiver störungen in der allgemeinärztlichen versorgung: Leitlinien der World Federation of Societies of Biological Psychiatry (WFSBP) Psychopharmakotherapie. 15: 239-264.  1
2007 Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: S1-207. PMID 18096106 DOI: 10.1017/S1461145707008255  1
2007 Bushe CJ, Leonard BE. Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials. The Journal of Clinical Psychiatry. 68: 1682-90. PMID 18052561  1
2007 Leonard BE. Psychopathology of depression. Drugs of Today (Barcelona, Spain : 1998). 43: 705-16. PMID 17987223 DOI: 10.1358/dot.2007.43.10.1122223  1
2007 Myint AM, O'Mahony S, Kubera M, Kim YK, Kenny C, Kaim-Basta A, Steinbusch HW, Leonard BE. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. Journal of Psychopharmacology (Oxford, England). 21: 843-50. PMID 17984161 DOI: 10.1177/0269881107077165  1
2007 Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation. 14: 65-71. PMID 17713352 DOI: 10.1159/000107420  1
2007 Leonard BE. Inflammation, depression and dementia: are they connected? Neurochemical Research. 32: 1749-56. PMID 17705097 DOI: 10.1007/s11064-007-9385-y  1
2007 Myint AM, Kim YK, Verkerk R, Park SH, Scharpé S, Steinbusch HW, Leonard BE. Tryptophan breakdown pathway in bipolar mania. Journal of Affective Disorders. 102: 65-72. PMID 17270276 DOI: 10.1016/j.jad.2006.12.008  1
2007 Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. Journal of Affective Disorders. 98: 143-51. PMID 16952400 DOI: 10.1016/j.jad.2006.07.013  1
2007 Navrátilová M, Jarkovský J, Cešková E, Leonard B, Sobotka L. Alzheimer disease: Malnutrition and nutritional support Clinical and Experimental Pharmacology and Physiology. 34: S11-S13. DOI: 10.1111/j.1440-1681.2007.04761.x  1
2006 Leonard BE. HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation. 13: 268-76. PMID 17709948 DOI: 10.1159/000104854  1
2006 Leonard BE, Myint A. Inflammation and depression: is there a causal connection with dementia? Neurotoxicity Research. 10: 149-60. PMID 17062376 DOI: 10.1007/BF03033243  1
2006 O'Mahony SM, Myint AM, van den Hove D, Desbonnet L, Steinbusch H, Leonard BE. Gestational stress leads to depressive-like behavioural and immunological changes in the rat. Neuroimmunomodulation. 13: 82-8. PMID 17033197 DOI: 10.1159/000096090  1
2006 Leonard BE, Myint A. Changes in the immune system in depression and dementia: causal or coincidental effects? Dialogues in Clinical Neuroscience. 8: 163-74. PMID 16889103  1
2006 Song C, Horrobin DF, Leonard BE. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry. 39: 88-99. PMID 16721697 DOI: 10.1055/s-2006-941557  1
2006 Leonard BE. Inflammation and depression: Is there a causal connection with dementia? | Zánět a deprese: Kauzální spojení s demencí? Psychiatrie. 10: 172-178.  1
2005 Leonard BE. The biochemistry of suicide. Crisis. 26: 153-5. PMID 16485839 DOI: 10.1027/0227-5910.26.4.153  1
2005 Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. European Psychiatry : the Journal of the Association of European Psychiatrists. 20: S302-6. PMID 16459240 DOI: 10.1016/S0924-9338(05)80180-4  1
2005 O'Mahony SM, Myint AM, Steinbusch H, Leonard BE. Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats. Neuroimmunomodulation. 12: 293-8. PMID 16166808 DOI: 10.1159/000087107  1
2005 Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders. 88: 167-73. PMID 16126278 DOI: 10.1016/j.jad.2005.07.008  1
2005 Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews. 29: 627-47. PMID 15925697 DOI: 10.1016/j.neubiorev.2005.03.010  1
2005 Roberts GM, Majoie HJ, Leenen LA, Bootsma HP, Kessels AG, Aldenkamp AP, Leonard BE. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam. Epilepsy & Behavior : E&B. 6: 366-72. PMID 15820345 DOI: 10.1016/j.yebeh.2005.01.005  1
2004 Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, Steinbusch HW. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Research. 129: 267-72. PMID 15661320 DOI: 10.1016/j.psychres.2004.08.005  1
2004 Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, Leonard BE. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 1129-34. PMID 15610925 DOI: 10.1016/j.pnpbp.2004.05.047  1
2004 Leonard BE. Sigma receptors and sigma ligands: background to a pharmacological enigma. Pharmacopsychiatry. 37: S166-70. PMID 15547782 DOI: 10.1055/s-2004-832674  1
2004 Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ, Akiskal H, Allain H, Ayuso-Gutiérrez J, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois M, Burrows G, ... ... Leonard B, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment World Journal of Biological Psychiatry. 5: 120-135. PMID 15346536 DOI: 10.1080/15622970410029924  1
2004 Song C, Leonard BE, Horrobin DF. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress (Amsterdam, Netherlands). 7: 43-54. PMID 15204032 DOI: 10.1080/10253890410001667188  1
2004 Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Human Psychopharmacology. 19: 151-80. PMID 15079851 DOI: 10.1002/hup.579  1
2004 Bushe C, Leonard B. Association between atypical antipsychotic agents and type 2 diabetes: Review of prospective clinical data British Journal of Psychiatry. 184: s87-s93. PMID 15056600 DOI: 10.1192/bjp.184.47.s87  1
2004 Song C, Phillips AG, Leonard BE, Horrobin DF. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Molecular Psychiatry. 9: 630-8. PMID 14699427 DOI: 10.1038/sj.mp.4001462  1
2004 Leonard BE. SSRIs, aggression and suicide - A cause for concern or the result of media hype? Irish Journal of Psychological Medicine. 21: 40-42.  1
2003 Song C, Phillips AG, Leonard B. Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. The European Journal of Neuroscience. 18: 1739-43. PMID 14622208 DOI: 10.1046/j.1460-9568.2003.02886.x  1
2003 Song C, Li X, Leonard BE, Horrobin DF. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. Journal of Lipid Research. 44: 1984-91. PMID 12837849 DOI: 10.1194/jlr.M300217-JLR200  1
2003 Shu SY, Bao XM, Wu YM, Wang J, Leonard B. Hippocampal long-term potentiation attenuated by lesions in the marginal division of neostriatum Neurochemical Research. 28: 743-747. PMID 12716025 DOI: 10.1023/A:1022865801813  1
2003 Shu SY, Bao XM, Ning Q, Wu YM, Wang J, Leonard BE. New component of the limbic system: Marginal division of the neostriatum that links the limbic system to the basal nucleus of Meynert. Journal of Neuroscience Research. 71: 751-7. PMID 12584733 DOI: 10.1002/jnr.10518  1
2003 Shu SY, Wu YM, Bao XM, Leonard B. Interactions among memory-related centers in the brain Journal of Neuroscience Research. 71: 609-616. PMID 12584720 DOI: 10.1002/jnr.10545  1
2003 Kelliher P, Kelly JP, Leonard BE, Sánchez C. Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test. Psychoneuroendocrinology. 28: 332-47. PMID 12573300 DOI: 10.1016/S0306-4530(02)00026-4  1
2003 Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonard BE, Lieberman JA, López-Ibor JJ, Van Raay B, Tornquist E, Twomey E. The usefulness and use of second-generation antipsychotic medications - An update Current Opinion in Psychiatry. 16: S1-S44. DOI: 10.1097/00001504-200304002-00001  1
2003 Harkin A, Kelly JP, Leonard BE. A review of the relevance and validity of olfactory bulbectomy as a model of depression Clinical Neuroscience Research. 3: 253-262. DOI: 10.1016/S1566-2772(03)00087-2  1
2002 Schüppel K, Brauer K, Härtig W, Grosche J, Earley B, Leonard BE, Brückner G. Perineuronal nets of extracellular matrix around hippocampal interneurons resist destruction by activated microglia in trimethyltin-treated rats. Brain Research. 958: 448-53. PMID 12470883 DOI: 10.1016/S0006-8993(02)03569-2  1
2002 Leonard BE, Song C. Changes in the immune system in rodent models of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 345-56. PMID 12466034 DOI: 10.1017/S1461145702003140  1
2002 Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain, Behavior, and Immunity. 16: 569-74. PMID 12401470 DOI: 10.1016/S0889-1591(02)00008-9  1
2002 Arolt V, Rothermundt M, Peters M, Leonard B. Immunological research in clinical psychiatry: Report on the consensus debate during the 7th expert meeting on psychiatry and immunology Molecular Psychiatry. 7: 822-826. PMID 12232771 DOI: 10.1038/sj.mp.4001115  1
2002 Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 461-75. PMID 12208564 DOI: 10.1016/S0924-977X(02)00057-3  1
2002 Darcy P, Kelly JP, Leonard BE, Henry JA. The effect of lofepramine and other related agents on the motility of Tetrahymena pyriformis. Toxicology Letters. 128: 207-14. PMID 11869831 DOI: 10.1016/S0378-4274(01)00542-2  1
2002 Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonard BE, Lieberman JA, López-Ibor JJ, Van Raay B, Twomey E, Kupfer DJ, Angst J, Cassano GB, Crow TJ, Freeman H, et al. The usefulness and use of second-generation antipsychotic medications: Preface Current Opinion in Psychiatry. 15: S1-S51. DOI: 10.1097/00001504-200203001-00001  1
2001 Leonard BE. Commentary on the nature and treatment of bipolar disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 2: 110-3. PMID 12587195 DOI: 10.3109/15622970109026798  1
2001 Leonard BE. An introduction to enantiomers in psychopharmacology. Human Psychopharmacology. 16: S79-S84. PMID 12404712 DOI: 10.1002/hup.335  1
2001 Caldwell J, Leonard BE. An introduction to the 'enantiomer debate' Human Psychopharmacology. 16: S65. PMID 12404709 DOI: 10.1002/hup.340  1
2001 Leonard BE. Editorial. Human Psychopharmacology. 16: 1. PMID 12404591 DOI: 10.1002/hup.176  1
2001 Leonard BE. Stress, norepinephrine and depression. Journal of Psychiatry & Neuroscience : Jpn. 26: S11-6. PMID 11590964 DOI: 10.1034/j.1601-5215.2002.140403.x  1
2001 Harkany T, O'Mahony S, Keijser J, Kelly JP, Kónya C, Borostyánkoi ZA, Görcs TJ, Zarándi M, Penke B, Leonard BE, Luiten PG. Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiology of Disease. 8: 667-78. PMID 11493031 DOI: 10.1006/nbdi.2001.0398  1
2001 Harkin A, Connor TJ, Mulrooney J, Kelly JP, Leonard BE. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sciences. 68: 1367-82. PMID 11388689 DOI: 10.1016/S0024-3205(00)01039-0  1
2001 Leonard BE. The immune system, depression and the action of antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 767-80. PMID 11383977 DOI: 10.1016/S0278-5846(01)00155-5  1
2001 Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects? International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 19: 305-12. PMID 11337199 DOI: 10.1016/S0736-5748(01)00014-4  1
2001 Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE. Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology. 154: 177-88. PMID 11314680 DOI: 10.1007/s002130000630  1
2001 Ryan PM, Kelly JP, Chambers PL, Leonard BE. The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat. Pharmacology & Toxicology. 88: 59-66. PMID 11169163  1
2000 Cryan JF, Leonard BE. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Human Psychopharmacology. 15: 113-135. PMID 12404340 DOI: 10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W  1
2000 Nolan Y, Connor TJ, Kelly JP, Leonard BE. Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1393-401. PMID 11458992 DOI: 10.1007/s007020070003  1
2000 Harkin A, Nally R, Kelly JP, Leonard BE. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1213-27. PMID 11129111 DOI: 10.1007/s007020070035  1
2000 Feighner JP, Ehrensing RH, Kastin AJ, Leonard BE, Sverdlov L, Nicolau G, Patel A, Hlavka J, Abajian H, Noble JF. A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression. Journal of Affective Disorders. 61: 119-26. PMID 11099750 DOI: 10.1016/S0165-0327(99)00187-1  1
2000 Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, Leonard BE, Gandon J, de Certaines JD. An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Research. 879: 193-9. PMID 11011022 DOI: 10.1016/S0006-8993(00)02619-6  1
2000 Connor TJ, Kelly JP, McGee M, Leonard BE. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sciences. 67: 1601-12. PMID 10983854 DOI: 10.1016/S0024-3205(00)00743-8  1
2000 Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiology & Behavior. 69: 531-9. PMID 10913793 DOI: 10.1016/S0031-9384(00)00213-4  1
2000 Leonard BE. Evidence for a biochemical lesion in depression. The Journal of Clinical Psychiatry. 61: 12-7. PMID 10775019  1
2000 Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, Biochemistry, and Behavior. 65: 591-7. PMID 10764911 DOI: 10.1016/S0091-3057(99)00192-6  1
2000 Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology. 46: 223-35. PMID 10741902 DOI: 10.1016/S0162-3109(99)00180-0  1
2000 Wrynn AS, Sebens JB, Koch T, Leonard BE, Korf J. Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset. Brain Research. Molecular Brain Research. 76: 7-17. PMID 10719210 DOI: 10.1016/S0169-328X(99)00326-5  1
2000 Cryan JF, Harkin A, Naughton M, Kelly JP, Leonard BE. Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. European Journal of Pharmacology. 390: 275-85. PMID 10708734 DOI: 10.1016/S0014-2999(00)00012-1  1
2000 Harkin A, Kelly JP, Frawley J, O'Donnell JM, Leonard BE. Test conditions influence the response to a drug challenge in rodents. Pharmacology, Biochemistry, and Behavior. 65: 389-98. PMID 10683478 DOI: 10.1016/S0091-3057(99)00210-5  1
2000 Connor TJ, Harkin A, Kelly JP, Leonard BE. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment. Neuroimmunomodulation. 7: 27-35. PMID 10601816  1
2000 Leonard BE. Peripheral markers of depression Current Opinion in Psychiatry. 13: 61-68. DOI: 10.1097/00001504-200001000-00011  1
2000 Leonard BE. Chapter 9 Biological aspects of depression Principles of Medical Biology. 14: 179-205. DOI: 10.1016/S1569-2582(00)80011-2  1
2000 Leonard BE. Stress, depression and the immune system Stress Medicine. 16: 133-137. DOI: 10.1002/(SICI)1099-1700(200004)16:3<133::AID-SMI876>3.0.CO;2-9  1
2000 Naughton M, Mulrooney JB, Leonard BE. Antidepressants and violence: Cause for concern or media hype? Human Psychopharmacology. 15: iii-iv.  1
2000 Leonard BE. Noradrenaline and depression Reviews in Contemporary Pharmacotherapy. 11: 257-266.  1
1999 Dredge K, Connor TJ, Kelly JP, Leonard BE. Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. International Journal of Immunopharmacology. 21: 663-73. PMID 12609461 DOI: 10.1016/S0192-0561(99)00042-9  1
1999 Darcy P, Dredge K, Kellehir P, Kelly JP, Leonard BE, Chambers PL. Acute toxicity profile of maprotiline in the rat. Pharmacology & Toxicology. 85: 276-81. PMID 10628903  1
1999 Kelly JP, Nicolau G, Redmond A, Leonard BE, Noble J, Sverdlov L, Molinar R, Kastin AJ, Ehrensing RH, Feighner JP. The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. Journal of Affective Disorders. 55: 231-5. PMID 10628893 DOI: 10.1016/S0165-0327(99)00018-X  1
1999 Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sciences. 65: 1773-86. PMID 10576557 DOI: 10.1016/S0024-3205(99)00430-0  1
1999 Cryan JF, Kelliher P, Kelly JP, Leonard BE. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. Journal of Psychopharmacology (Oxford, England). 13: 278-83. PMID 10512084  1
1999 Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. European Journal of Pharmacology. 379: 125-33. PMID 10497898 DOI: 10.1016/S0014-2999(99)00492-6  1
1999 Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology. 145: 303-8. PMID 10494579 DOI: 10.1007/s002130051062  1
1999 Leonard BE, Song C. Stress, depression, and the role of cytokines. Advances in Experimental Medicine and Biology. 461: 251-65. PMID 10442177 DOI: 10.1007/978-0-585-37970-8_14  1
1999 Cryan JF, McGrath C, Leonard BE, Norman TR. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacology, Biochemistry, and Behavior. 63: 333-8. PMID 10371664 DOI: 10.1016/S0091-3057(98)00245-7  1
1999 Connor TJ, Song C, Leonard BE, Anisman H, Merali Z. Stressor-induced alterations in serotonergic activity in an animal model of depression. Neuroreport. 10: 523-8. PMID 10208583 DOI: 10.1097/00001756-199902250-00015  1
1999 Redmond AM, Kelly JP, Leonard BE. The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression. Pharmacology, Biochemistry, and Behavior. 62: 619-23. PMID 10208367 DOI: 10.1016/S0091-3057(98)00181-6  1
1999 Redmond AM, Harkin A, Kelly JP, Leonard BE. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 165-70. PMID 10082243 DOI: 10.1016/S0924-977X(98)00023-6  1
1999 Kelly JP, Leonard BE. An investigation of the antidepressant properties of lofepramine and its desmethylated metabolites in the forced swim and olfactory bulbectomized rat models of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 101-5. PMID 10082234 DOI: 10.1016/S0924-977X(98)00010-8  1
1999 Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. European Journal of Pharmacology. 364: 123-32. PMID 9932714 DOI: 10.1016/S0014-2999(98)00838-3  1
1999 Leonard BE. New developments in the pharmacological treatment of anxiety Human Psychopharmacology. 14: S52-S59. DOI: 10.1002/(SICI)1099-1077(199908)14:1+3.0.CO;2-G  1
1999 Connor TJ, McNamara MG, Kelly JP, Leonard BE. 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat Human Psychopharmacology. 14: 95-104. DOI: 10.1002/(SICI)1099-1077(199903)14:2<95::AID-HUP72>3.0.CO;2-7  1
1999 Leonard BE. Neuropharmacology of antidepressants that modify central noradrenergic and serotonergic function: A short review Human Psychopharmacology. 14: 75-81. DOI: 10.1002/(SICI)1099-1077(199903)14:2<75::AID-HUP68>3.0.CO;2-X  1
1999 Leonard BE. Therapeutic applications of benzodiazepine receptor ligands in anxiety Human Psychopharmacology. 14: 125-135. DOI: 10.1002/(SICI)1099-1077(199903)14:2<125::AID-HUP79>3.0.CO;2-X  1
1999 Leonard BE. Movement disorders and abuse potential of the selective serotonin reuptake inhibitors Human Psychopharmacology. 14: 1-6. DOI: 10.1002/(SICI)1099-1077(199901)14:1<1::AID-HUP38>3.0.CO;2-L  1
1999 Wrynn AS, Donohoe N, Leonard BE. A morphological investigation within the anterior cortical nucleus of the amygdala following olfactory bulbectomy Medical Science Research. 27: 513-515.  1
1999 Shen Y, Connor TJ, Kelly JP, Leonard BE. Effects of chronic dietary supplementation with ω3 and ω6 fatty acid rich oils on lipopolysaccharide-induced behavioural responses and interleukin-1β secretion in the rat Medical Science Research. 27: 291-294.  1
1998 Healy DG, Kelly JP, Leonard BE. Corticosterone influences the NMDA receptor antagonist MK-801 induced hyperactivity in the rat. Biochemical Society Transactions. 26: S23. PMID 10909781  1
1998 Kelly JP, Leonard BE. Models and responses in depression and aggression. Biochemical Society Transactions. 26: 61-5. PMID 10909758  1
1998 Cryan JF, McGrath C, Leonard BE, Norman TR. Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? European Journal of Pharmacology. 352: 23-8. PMID 9718263 DOI: 10.1016/S0014-2999(98)00402-6  1
1998 Faherty CJ, Harkin AJ, Leonard BE. The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment. European Journal of Pharmacology. 346: 15-21. PMID 9617747 DOI: 10.1016/S0014-2999(98)00041-7  1
1998 Song C, Leonard BE. Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. European Journal of Pharmacology. 345: 79-87. PMID 9593598 DOI: 10.1016/S0014-2999(97)01592-6  1
1998 Harkany T, O'Mahony S, Kelly JP, Soós K, Törõ I, Penke B, Luiten PG, Nyakas C, Gulya K, Leonard BE. Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behavioural Brain Research. 90: 133-45. PMID 9580273 DOI: 10.1016/S0166-4328(97)00091-0  1
1998 Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84: 923-33. PMID 9579794 DOI: 10.1016/S0306-4522(97)00533-2  1
1998 O'Mahony S, Harkany T, Rensink AA, Abrahám I, De Jong GI, Varga JL, Zarándi M, Penke B, Nyakas C, Luiten PG, Leonard BE. Beta-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockade. Brain Research Bulletin. 45: 405-11. PMID 9527015 DOI: 10.1016/S0361-9230(97)00405-X  1
1998 Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE. Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology. 38: 253-60. PMID 9506825 DOI: 10.1016/S0162-3109(97)00084-2  1
1998 Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences. 62: 583-606. PMID 9472719 DOI: 10.1016/S0024-3205(97)00990-9  1
1998 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacology, Biochemistry, and Behavior. 59: 171-7. PMID 9443552 DOI: 10.1016/S0091-3057(97)00316-X  1
1998 Leonard BE. Advances in the drug treatment of Alzheimer's disease Human Psychopharmacology. 13: 83-90. DOI: 10.1002/(SICI)1099-1077(199803)13:2<83::AID-HUP956>3.0.CO;2-F  1
1998 Leonard BE. The role of reboxetine, a selective noradrenaline reuptake inhibitor, in the treatment of depression: Introduction Human Psychopharmacology. 13: S1. DOI: 10.1002/(SICI)1099-1077(199802)13:1+3.0.CO;2-O  1
1998 Dredge K, Kelly JP, Leonard BE. Effect of single dose of imipramine on some immunotoxicological parameters in the rat Medical Science Research. 26: 789-792.  1
1998 Nugent DF, Leonard BE. Platelet abnormalities in depression Journal of Serotonin Research. 4: 251-266.  1
1997 Borsini F, Cesana R, Kelly J, Leonard BE, McNamara M, Richards J, Seiden L. BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology. 134: 378-86. PMID 9452180 DOI: 10.1007/s002130050474  1
1997 Leonard BE. The role of noradrenaline in depression: a review. Journal of Psychopharmacology (Oxford, England). 11: S39-47. PMID 9438232  1
1997 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacology, Biochemistry, and Behavior. 58: 961-7. PMID 9408201 DOI: 10.1016/S0091-3057(97)00028-2  1
1997 Caldwell MA, Reymann JM, Allain H, Leonard BE, Bentué-Ferrer D. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Research. 771: 305-18. PMID 9401751 DOI: 10.1016/S0006-8993(97)00817-2  1
1997 Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: an update. Pharmacology & Therapeutics. 74: 299-316. PMID 9352586 DOI: 10.1016/S0163-7258(97)00004-1  1
1997 O'Mahony S, Noonan D, Harkány T, De Jong GI, Nyakas C, Leonard BE. Ifenprodil attenuates the loss of parietal cortical parvalbumin immunoreactivity after focal cerebral ischemia in the mouse. Neurobiology (Budapest, Hungary). 5: 79-82. PMID 9302704  1
1997 Redmond AM, Kelly JP, Leonard BE. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacology, Biochemistry, and Behavior. 58: 355-9. PMID 9300592 DOI: 10.1016/S0091-3057(97)00259-1  1
1997 Song C, Earley B, Leonard BE. Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat. Neuropsychobiology. 35: 200-4. PMID 9246222  1
1997 De Souza I, Kelly JP, Harkin AJ, Leonard BE. An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxymethamphetamine (MDMA) in the rat. Pharmacology & Toxicology. 80: 207-10. PMID 9181598  1
1997 Leonard BE. Noradrenaline in basic models of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 7: S11-6; discussion S7. PMID 9169306 DOI: 10.1016/S0924-977X(97)00415-X  1
1997 Cryan JF, Redmond AM, Kelly JP, Leonard BE. The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 7: 109-14. PMID 9169298 DOI: 10.1016/S0924-977X(96)00391-4  1
1997 Maginn M, Kelly JP, Leonard BE. Protective effects of vanoxeamine (GBR 12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia. Pharmacology, Biochemistry, and Behavior. 56: 727-35. PMID 9130300 DOI: 10.1016/S0091-3057(96)00409-1  1
1997 Song C, Earley B, Leonard BE. Effect of chronic treatment with piracetam and tacrine on some changes caused by thymectomy in the rat brain. Pharmacology, Biochemistry, and Behavior. 56: 697-704. PMID 9130296 DOI: 10.1016/S0091-3057(96)00410-8  1
1997 Leonard BE. The role of the individual in history and related matters. Journal of Psychopharmacology (Oxford, England). 11: 95-6. PMID 9097900  1
1997 Faherty CJ, Earley B, Leonard BE. Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. Journal of Psychopharmacology (Oxford, England). 11: 53-8. PMID 9097894 DOI: 10.1177/026988119701100114  1
1997 Leonard BE. Neurotransmitters in depression: noradrenaline and serotonin and their interactions. Journal of Clinical Psychopharmacology. 17: 1S. PMID 9090572  1
1997 O'Connell AW, Strada O, Earley B, Leonard BE. Altered expression of amyloid protein precursor mRNA in the rat hippocampus following trimethyltin intoxication: an in situ hybridization study. Neurochemistry International. 30: 313-20. PMID 9041563 DOI: 10.1016/S0197-0186(96)00052-6  1
1997 Leonard BE. Conclusion European Neuropsychopharmacology. 7: S75-S76. DOI: 10.1016/S0924-977X(97)00422-7  1
1997 Leonard BE, Song C. Changes in the immune-endocrine interrelationships in anxiety and depression Stress Medicine. 13: 217-227. DOI: 10.1002/(SICI)1099-1700(199710)13:4<217::AID-SMI742>3.0.CO;2-I  1
1997 Redmond AM, Leonard BE. An evaluation of the role of the noradrenergic system in the neurobiology of depression: A review Human Psychopharmacology. 12: 407-430. DOI: 10.1002/(SICI)1099-1077(199709/10)12:5<407::AID-HUP918>3.0.CO;2-1  1
1997 Song C, Leonard BE. Changes in behavior, neurotransmitters and neutrophil function in olfactory bulbectomized rats: Effects of chronic desipramine treatment Human Psychopharmacology. 12: 99-103. DOI: 10.1002/(SICI)1099-1077(199703/04)12:2<99::AID-HUP842>3.0.CO;2-P  1
1997 McGrath C, Kelly JP, McHugh MF, Leonard BE. Effect of phencyclidine and apomorphine administration in the olfactory bulbectomised rat Medical Science Research. 25: 829-831.  1
1997 Leonard BE. Neuropsychopharmacology: Changing the face of psychotropic drug discovery Cns Spectrums. 2: 26-34.  1
1997 Nsimba SED, Kelly JP, Leonard BE. Effect of chronic rafoxanide administration on behavioural and physiological parameters in the rat Indian Journal of Pharmacology. 29: 289-295.  1
1997 Connor TJ, Kelly JP, Leonard BE. Effect of acute desipramine treatment on immunological parameters in the rat Medical Science Research. 25: 209-211.  1
1997 Nsimba SED, Kelly JP, Leonard BE. Effect of acute and chronic haloperidol administration and apomorphine challenge on the behavioural parameters in rats Indian Journal of Pharmacology. 29: 15-19.  1
1997 Nsimba SED, Kelly JP, Leonard BE. The interaction between chlorpromazine and apomorphine on temperature response in the rat Journal of Serotonin Research. 3: 161-167.  1
1996 Kelly JP, Leonard BE. Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats. Journal of Psychopharmacology (Oxford, England). 10: 153-6. PMID 22302893 DOI: 10.1177/026988119601000211  1
1996 McNamara MG, Kelly JP, Leonard BE. Some behavioural and neurochemical effects of ipsapirone in two rodent models of depression. Journal of Psychopharmacology (Oxford, England). 10: 126-33. PMID 22302889 DOI: 10.1177/026988119601000207  0.72
1996 Ryan PM, Kelly JP, Chambers PL, Leonard BE. The characterization of oxotremorine-induced hypothermic response in the rat. Pharmacology & Toxicology. 79: 238-40. PMID 8936556  1
1996 Caldwell MA, Reymann JM, Bentue-Ferrer D, Allain H, Leonard BE. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat. Neuropsychobiology. 34: 117-24. PMID 8916068  1
1996 Song C, Earley B, Leonard BE. Behavioural and immunological effects of the antihistamine terfenadine in olfactory bulbectomized rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 157-62. PMID 8880073  0.36
1996 Earley B, Canney M, Clune B, Caldwell M, Leonard BE, Junien JL. The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia. Neurochemistry International. 28: 509-21. PMID 8792332  1
1996 Song C, Earley B, Leonard BE. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression. Brain, Behavior, and Immunity. 10: 1-16. PMID 8735565 DOI: 10.1006/brbi.1996.0001  0.36
1996 Leonard BE, Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacology, Biochemistry, and Behavior. 54: 299-303. PMID 8728571  0.36
1996 Leonard BE. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychotherapy and Psychosomatics. 65: 66-75. PMID 8711084  1
1996 Leonard BE. New approaches to the treatment of depression. The Journal of Clinical Psychiatry. 57: 26-33. PMID 8636063  1
1996 Cryan JF, Redmond AM, Kelly JP, Leonard BE. Does the serenic eltoprazine have antidepressant potential? - An investigation in three rodent paradigms Medical Science Research. 24: 719-720.  1
1996 Leonard BE. Pharmacology of new antidepressants: From the laboratory to the clinic: Introduction Journal of Clinical Psychiatry. 57: 3.  1
1996 Leonard BE. Litigation and the toxicity of psychotropic drugs Irish Journal of Psychological Medicine. 13: 88-89.  1
1996 Leonard BE. Tricyclic antidepressants: Effective, cheap but are they safe? Journal of Psychopharmacology. 10: 35-38.  1
1996 Leonard BE. Litigation and the toxicity of psychotropic drugs: A reply to Prof Patricia Casey Irish Journal of Psychological Medicine. 13: 170-171.  1
1995 Song C, Leonard BE. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation. 2: 263-73. PMID 8739199  0.36
1995 Song C, Earley B, Leonard BE. Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress? Annals of the New York Academy of Sciences. 771: 55-72. PMID 8597429  0.36
1995 Caldwell M, O'Neill M, Earley B, Kelly JP, Leonard BE. NG-nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia. European Journal of Pharmacology. 285: 203-6. PMID 8566140 DOI: 10.1016/0014-2999(95)00502-C  1
1995 McNamara MG, Kelly JP, Leonard BE. Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacology, Biochemistry, and Behavior. 52: 479-84. PMID 8545462  0.72
1995 Nugent DF, Dinan TG, Leonard BE. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. Journal of Affective Disorders. 33: 227-31. PMID 7790676  1
1995 Leonard BE. Critique. The involvement of neuromediation in alcohol abuse and alcoholism. Neurochemistry International. 26: 343-6. PMID 7633326 DOI: 10.1016/0197-0186(94)00141-G  1
1995 O'Neill M, Caldwell M, Earley B, Canney M, O'Halloran A, Kelly J, Leonard BE, Junien JL. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. European Journal of Pharmacology. 283: 217-25. PMID 7498313 DOI: 10.1016/0014-2999(95)00356-P  1
1995 Maginn M, Caldwell M, Kelly JP, Leonard BE. The effect of 2-amino-3-phosphonopropionic acid (AP-3) in the gerbil model of cerebral ischaemia. European Journal of Pharmacology. 282: 259-62. PMID 7498286 DOI: 10.1016/0014-2999(95)00400-F  1
1995 Leonard BE. Biological markers of serotonin receptors in depression and animal models of depression International Review of Psychiatry. 7: 69-83. DOI: 10.3109/09540269509022976  1
1995 Leonard BE. Mechanisms of Action of Antidepressants Cns Drugs. 4: 1-12. DOI: 10.2165/00023210-199500041-00003  1
1995 Leonard BE. SSRI differentiation: Pharmacology and pharmacokinetics Human Psychopharmacology. 10. DOI: 10.1002/hup.470100903  1
1995 Leonard BE. Mirtazapine. Noradrenergic and specific serotonergic antidepressant (NaSSA). Editorial Human Psychopharmacology. 10. DOI: 10.1002/hup.470100802  1
1995 Kelly JP, Leonard BE. The contribution of pre-clinical drug evaluation in predicting the clinical profile of the selective serotonin reuptake inhibitor paroxetine Journal of Serotonin Research. 2: 27-46.  1
1994 Leonard BE, Nicholson CD. Sigma ligands as potential psychotropic drugs. Journal of Psychopharmacology (Oxford, England). 8: 64-5. PMID 22298484 DOI: 10.1177/026988119400800112  1
1994 Nugent DF, Dinan TG, Leonard BE. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. Journal of Affective Disorders. 31: 61-6. PMID 8046161  1
1994 Leonard BE. Serotonin receptors--where are they going? International Clinical Psychopharmacology. 9: 7-17. PMID 8021439  1
1994 Song C, Killeen AA, Leonard BE. Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. Neuropsychobiology. 30: 24-8. PMID 7969855  0.36
1994 Leonard BE. Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences. Journal of Psychosomatic Research. 38: 69-87. PMID 7799254 DOI: 10.1016/0022-3999(94)90138-4  1
1994 Kelly JP, Leonard BE. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33: 1011-6. PMID 7531300 DOI: 10.1016/0028-3908(94)90160-0  1
1994 Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. Journal of Affective Disorders. 30: 283-8. PMID 7516941  0.36
1994 Leonard BE. Biochemical Strategies for the Development of Antidepressants Cns Drugs. 1: 285-304. DOI: 10.2165/00023210-199401040-00006  1
1994 Leonard BE. The enigma of sigma receptors European Neuropsychopharmacology. 4: 174-175. DOI: 10.1016/0924-977X(94)90020-5  1
1994 Leonard BE. Introductory remarks Human Psychopharmacology. 9. DOI: 10.1002/hup.470090701  1
1993 Leonard BE. In search of black bile: do antidepressants act by changing endogenous endocoids in the depressed patient? Journal of Psychopharmacology (Oxford, England). 7: 1-3. PMID 22290364 DOI: 10.1177/0269881193007001021  1
1993 Dinan TG, Leonard BE. Triazolam. As safe as other benzodiazepines. Bmj (Clinical Research Ed.). 306: 1475. PMID 8518653  1
1993 Leonard BE. Endocoids in depression: do antidepressants alter endocoids that affect the serotonergic system? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 505-14. PMID 8395698 DOI: 10.1016/0278-5846(93)90001-9  1
1993 McAdams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 971-84. PMID 8278606 DOI: 10.1016/0278-5846(93)90024-M  1
1993 Morrissey M, Leonard BE. A survey of final year medical students at University College, Galway. Irish Medical Journal. 86: 154-5. PMID 8225919  1
1993 Leonard BE. Commentary on the mode of action of benzodiazepines. Journal of Psychiatric Research. 27: 193-207. PMID 7908333 DOI: 10.1016/0022-3956(93)90028-Z  1
1993 Leonard BE. 5HT receptor subtypes in anxiety disorders and depression European Neuropsychopharmacology. 3: 305-306. DOI: 10.1016/0924-977X(93)90087-3  1
1992 Leonard BE. Sub-types of serotonin receptors: biochemical changes and pharmacological consequences. International Clinical Psychopharmacology. 7: 13-21. PMID 1624753  1
1992 McAdams C, Leonard BE. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients. International Clinical Psychopharmacology. 7: 81-5. PMID 1487625  1
1992 McAdams C, Colohan FJ, Brophy J, Leonard BE. Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biological Psychiatry. 32: 296-8. PMID 1420645 DOI: 10.1016/0006-3223(92)90112-D  1
1992 Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs. 43: 3-9; discussion 9-10. PMID 1378371 DOI: 10.2165/00003495-199200432-00003  1
1992 Song C, Leonard BE. Effect of thymopeptides on behaviour and some immunological responses in olfactory bulbectomised rats Medical Science Research. 20: 929-930.  1
1991 Leonard BE, Everitt B. CCK and anxiety. Journal of Psychopharmacology (Oxford, England). 5: 439-40. PMID 22282856 DOI: 10.1177/026988119100500441  1
1991 Leonard BE. Pharmacological and biochemical aspects of therapy-resistant depression. International Clinical Psychopharmacology. 6: 13-28; discussion 28. PMID 1757716  1
1991 Léonard BE. Antidepressants. Current concepts of mode of action. L'EncéPhale. 17: 127-31. PMID 1677887  1
1990 O'Neill B, Leonard BE. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression. Journal of Affective Disorders. 19: 265-72. PMID 2146303 DOI: 10.1016/0165-0327(90)90104-G  1
1990 Leonard BE. Stress and the immune system: Immunological aspects of depressive illness International Review of Psychiatry. 2: 321-330. DOI: 10.3109/09540269009026603  1
1990 Leonard BE. Mechanisms of action of benzodiazepines Journal of Psychiatric Research. 24: 63-64. DOI: 10.1016/0022-3956(90)90088-8  1
1990 Leonard BE. Toxicity and adverse effects of psychotropic drugs: Can we expect an increase in litigation? Journal of the Irish Colleges of Physicians and Surgeons. 19: 252-254.  1
1990 Leonard BE. Changes in biogenic amine neurotransmitters in panic disorder Stress Medicine. 6: 267-274.  1
1990 Leonard BE. Research strategies for the treatment of Alzheimer's disease Medical Science Research. 18: 663-665.  1
1989 Keane B, Leonard BE. Rodent models of alcoholism: a review. Alcohol and Alcoholism (Oxford, Oxfordshire). 24: 299-309. PMID 2675861  1
1989 Leonard BE. Toxicity of antidepressants in overdose. International Journal of Clinical Pharmacology Research. 9: 101-10. PMID 2654033  1
1989 Leonard BE. Safety of amoxapine. Lancet. 2: 808. PMID 2571052 DOI: 10.1016/S0140-6736(89)90878-7  1
1988 O'Connor WT, Leonard BE. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 41-51. PMID 3363165 DOI: 10.1016/0278-5846(88)90060-7  1
1988 Leonard BE. Biochemical aspects of therapy-resistant depression. The British Journal of Psychiatry : the Journal of Mental Science. 152: 453-9. PMID 3048524  1
1988 Leonard BE. Pharmacological effects of serotonin reuptake inhibitors. The Journal of Clinical Psychiatry. 49: 12-7. PMID 3045106  1
1988 Leonard BE. Alcohol as a social teratogen. Progress in Brain Research. 73: 305-17. PMID 2901777 DOI: 10.1016/S0079-6123(08)60512-9  1
1988 Leonard BE. Lofepramine: pharmacology and mode of action. International Clinical Psychopharmacology. 3: 25-38. PMID 2851020  1
1988 Leonard BE. Stress, the immune system and psychiatric illness Stress Medicine. 4: 207-213.  1
1988 Leonard BE. The immune system and depression Human Psychopharmacology. 3: 157-158.  1
1987 Leonard BE. Ethanol as a neurotoxin. Biochemical Pharmacology. 36: 2055-9. PMID 3300652 DOI: 10.1016/0006-2952(87)90129-8  1
1987 Leonard BE. A comparison of the pharmacological properties of the novel tricyclic antidepressant lofepramine with its major metabolite, desipramine: a review. International Clinical Psychopharmacology. 2: 281-97. PMID 2891742  1
1987 Leonard BE. Stress, the immune system and mental illness Stress Medicine. 3: 257-258.  1
1986 Menez JF, Leonard BE. The effect of a putative antidepressant, an O2-substituted derivative of barbitone on apomorphine induced hypomotility. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 703-8. PMID 3809521 DOI: 10.1016/0278-5846(86)90054-0  1
1986 O'Connor WT, Leonard BE. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus. Neuropharmacology. 25: 267-70. PMID 3703175 DOI: 10.1016/0028-3908(86)90250-9  1
1986 Leonard BE. Toxicity of antidepressants. Lancet. 2: 1105. PMID 2877264 DOI: 10.1016/S0140-6736(86)90511-8  1
1986 Leonard BE. Is ethanol a neurotoxin?: The effects of ethanol on neuronal structure and function. Alcohol and Alcoholism (Oxford, Oxfordshire). 21: 325-38. PMID 2434114  1
1986 O'Neill B, Leonard BE. Is there an abnormality in neutrophil phagocytosis in depression? Ircs Medical Science. 14: 802-803.  1
1985 O'Connor WT, Earley B, Leonard BE. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression. British Journal of Clinical Pharmacology. 19: 49S-56S. PMID 2859878  1
1985 Leonard BE. New antidepressants and the biology of depression Stress Medicine. 1: 9-16.  1
1985 Keane B, Leonard BE. The effect of ethanol administration on the activities of synaptosomal Ca2+-ATPases in rat brain Biochemical Society Transactions. 13: 969-970.  1
1985 Burke M, Leonard BE. Effects of naloxone on some behavioural and biochemical actions of dextropropoxyphene Ircs Medical Science. 13: 236-237.  1
1984 Leonard BE. GABA and endocrine regulation. Neurochemistry International. 6: 17-22. PMID 20488015 DOI: 10.1016/0197-0186(84)90021-4  1
1984 Moloney B, Leonard BE. Pre-natal and post-natal effects of alcohol in the rat--I. Changes in body weight and exploratory activity. Alcohol and Alcoholism (Oxford, Oxfordshire). 19: 131-6. PMID 6497957  1
1984 Leonard BE. Neurotransmitter markers of depression. The Australian and New Zealand Journal of Psychiatry. 18: 307-12. PMID 6151835 DOI: 10.3109/00048678409158792  1
1984 Moloney B, Leonard BE. Pre-natal and post-natal effects of alcohol in the rat--II. Changes in gamma-aminobutyric acid concentration and adenosine triphosphatase activity in the brain. Alcohol and Alcoholism (Oxford, Oxfordshire). 19: 137-40. PMID 6149760  1
1984 Leonard BE. Pharmacology of new antidepressants. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8: 97-108. PMID 6145191 DOI: 10.1016/0278-5846(84)90140-4  1
1984 Corbett R, Leonard BE. Effects of carnitine on changes caused by chronic administration of alcohol. Neuropharmacology. 23: 269-71. PMID 6143279 DOI: 10.1016/0028-3908(84)90069-8  1
1984 Leonard BE. Inter-relationship between neurotransmitters. Neuropharmacology. 23: 213-8. PMID 6143277 DOI: 10.1016/0028-3908(84)90062-5  1
1984 Leonard BE. The olfactory bulbectomized rat as a model of depression. Polish Journal of Pharmacology and Pharmacy. 36: 561-9. PMID 6099892  1
1984 Leonard BE. Possible relationships between thiamine, carnitine, polyunsaturated fatty acids and the neurotoxicity of alcohol. Alcohol and Alcoholism (Oxford, Oxfordshire). 19: 97-9. PMID 6093831  1
1984 Jancsár SM, Leonard BE. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat. Neuropharmacology. 23: 1065-70. PMID 6083502 DOI: 10.1016/0028-3908(84)90130-8  1
1983 Keane B, Leonard BE. Changes in "open field" behaviour and in some membrane-bound enzymes following the chronic administration of ethanol to the rat. Neuropharmacology. 22: 555-7. PMID 6134253 DOI: 10.1016/0028-3908(83)90179-X  1
1982 Leonard BE. Current status of the biogenic amine theory of depression. Neurochemistry International. 4: 339-50. PMID 20487885 DOI: 10.1016/0197-0186(82)90074-2  1
1982 Leonard BE. On the mode of action of mianserin. Advances in Biochemical Psychopharmacology. 31: 301-19. PMID 6282060  1
1982 Leonard BE. Behavioural teratology: post-natal consequences of drug exposure in utero. Archives of Toxicology. Supplement. = Archiv FüR Toxikologie. Supplement. 5: 48-58. PMID 6125143  1
1982 Leonard BE. Neuropharmacology of anxiolytic drugs: A selected review of the field Drug Development Research. 2: 1-11.  1
1982 Kennedy BP, Leonard BE. Effect of clobazam and other benzodiazepines on gamma-aminobutyric acid (GABA)-turnover in stressful and nonstressful situations Drug Development Research. 2: 101-115.  1
1981 Leonard BE. Effect of psychotropic drugs administered to pregnant rats on the behaviour of the offspring. Neuropharmacology. 20: 1237-42. PMID 6119636  1
1981 Malony B, Leonard BE. Effects of alcohol on adenosine triphosphate activity in rat brain Irish Journal of Medical Science. 150: 344-345.  1
1980 Morinan A, Leonard BE. Some anatomical and physiological correlates of social isolation in the young rat. Physiology & Behavior. 24: 637-40. PMID 7375588 DOI: 10.1016/0031-9384(80)90265-6  1
1980 Leonard BE. Pharmacological properties of some "second generation" antidepressant drugs. Neuropharmacology. 19: 1175-83. PMID 6449676 DOI: 10.1016/0028-3908(80)90198-7  1
1980 Kennedy B, Leonard BE. Similarity between the action of nicotinamide and diazepam on neurotransmitter metabolism in the rat [proceedings]. Biochemical Society Transactions. 8: 59-60. PMID 6154611  1
1980 Kenny M, Leonard BE. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs. Journal of Neuroscience Research. 5: 291-8. PMID 6107385 DOI: 10.1002/jnr.490050405  1
1980 Kenny M, Leonard BE. The effects of strain differences and emotional status of rats on the behavioural and neurochemical effects of chronic treatment with apomorphine. Progress in Neuro-Psychopharmacology. 4: 161-70. PMID 6105688 DOI: 10.1016/0364-7722(80)90033-8  1
1980 Leonard BE. Behavioural teratology: Post natal consequences of drug exposure in utero Journal of Pharmacotherapy. 3: 126-130.  1
1979 Earley CJ, Leonard BE. Androgens, estrogens and their anti-hormones: effects on body weight and food consumption. Pharmacology, Biochemistry, and Behavior. 11: 211-4. PMID 504300 DOI: 10.1016/0091-3057(79)90015-7  1
1979 Leonard BE. Pharmacological and biochemical aspects of hyperkinetic disorders. Neuropharmacology. 18: 923-9. PMID 43483 DOI: 10.1016/0028-3908(79)90156-4  1
1979 Leonard BE. Recent advances in antidepressant medication Journal of Pharmacotherapy. 2: 44-49.  1
1979 Brougham PP, Leonard BE. The effects of ovarian steroids on the tryptaminergic system in the rat brain Irish Journal of Medical Science. 148: 244.  1
1978 Lynch MA, Leonard BE. Changes in brain gamma-aminobutyric acid concentrations following acute and chronic amphetamine administration and during post amphetamine depression. Biochemical Pharmacology. 27: 1853-5. PMID 568471 DOI: 10.1016/0006-2952(78)90032-1  1
1978 Kenny M, Leonard BE. Neurochemical and behavioral correlates of chronic apomorphine administration in the rat. Advances in Biochemical Psychopharmacology. 19: 347-9. PMID 567934  1
1978 Leonard BE, Kenny M. Some neuropharmacological aspects of schizophrenia: a short review. Irish Journal of Medical Science. 147: 43-8. PMID 567632 DOI: 10.1007/BF02947903  1
1978 McNulty J, Leonard BE. The acute effects of amphetamine, chlorpromazine, amitriptyline and lithium on adenosine 5-triphosphatase activity in the cortex of the rat brain. Biochemical Pharmacology. 27: 132-3. PMID 145866 DOI: 10.1016/0006-2952(78)90273-3  1
1978 Leonard BE. Mianserin, an antidepressant with a unique neuropharmacological profile. Acta Psychiatrica Belgica. 78: 770-80. PMID 35926  1
1978 Lynch MA, Leonard BE. Changes in brain γ-aminobutyric acid concentrations following acute and chronic amphetamine administration and during post amphetamine depression Irish Journal of Medical Science. 147: 324-325.  1
1977 Leonard BE. Some effects of mianserine (ORG GB 94) on amine metabolism in the rat brain Pharmakopsychiatrie Und Neuropsychopharmakologie. 10: 92-95. PMID 616924  1
1977 Leonard BE. Drug-induced changes in brain tyrosine hydroxylase activity in vivo Neuropharmacology. 16: 47-52. PMID 13325 DOI: 10.1016/0028-3908(77)90046-6  1
1977 Kenny M, Leonard BE. Induction of two types of stereotyped behaviour by low doses of apomorphine in the rat Irish Journal of Medical Science. 146: 90-91.  1
1976 Leonard BE. Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain Psychopharmacologia. 46: 11-18. PMID 1257360 DOI: 10.1007/BF00421543  1
1975 Leonard BE. Changes in rat brain monoamine metabolism following the acute administration of lithium chloride in combination with antidepressant drugs Archives Internationales De Pharmacodynamie Et De Therapie. 215: 202-207. PMID 1164088  1
1975 Leonard BE. A Study of the Neurohumoral Control of Glycolysis in the Mouse Brain in vivo: Role of Noradrenaline and Dopamine Zeitschrift Fur Naturforschung - Section C Journal of Biosciences. 30: 385-391. PMID 170752 DOI: 10.1515/znc-1975-5-614  1
1975 Leonard BE. The Effect of Org. GB 94, Imipramine and Chlorpromazine on the Concentrations of Some Amino Acids in 9 Regions of the Rat Brain Zeitschrift Fur Naturforschung - Section C Journal of Biosciences. 30: 838-840. PMID 130018 DOI: 10.1515/znc-1975-11-1229  1
1975 Leonard BE. The Effect of 5-Hydroxytryptamine and Histamine on Glycolysis in the Mouse Brain Zeitschrift Fur Naturforschung - Section C Journal of Biosciences. 30: 113-116. PMID 123388 DOI: 10.1515/znc-1975-1-222  1
1975 Leonard BE. Is it essential that antidepressant drugs should be inhibitors of brain monoamine uptake? Experimental Brain Research 1
1975 Leonard BE. Neurochemical and neuropharmacological aspects of depression International Review of Neurobiology. 357-387.  1
1975 Leonard BE, Rigter H. Is there a connection between passive avoidance behaviour, retrograde amnesia and hippocampal monoamine metabolism in the rat? Experimental Brain Research 1
1974 Leonard BE. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain Archives Internationales De Pharmacodynamie Et De Therapie. 207: 242-253. PMID 4363855  1
1973 Leonard BE. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain Psychopharmacologia. 32: 33-49. PMID 4743235 DOI: 10.1007/BF00421706  1
1972 Leonard BE. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors Archives Internationales De Pharmacodynamie Et De Therapie. 199: 94-107. PMID 5072195  1
1972 Leonard BE. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors Archives Internationales De Pharmacodynamie Et De Therapie. 199: 79-93. PMID 5072194  1
1972 Leonard BE. Anti-tremorine effects of some mono- and diacyloxytropanes Archives Internationales De Pharmacodynamie Et De Therapie. 196: 93-97. PMID 5059372  1
1972 Leonard BE. A comparison between the effects of phenoxybenzamine, phentolamine and propranolol on mouse brain glycolysis Biochemical Pharmacology. 21: 109-113. PMID 5058699 DOI: 10.1016/0006-2952(72)90256-0  1
1972 Leonard BE. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain British Journal of Pharmacology. 45. PMID 5041482  1
1972 Leonard BE. Effect of four amphetamines on brain biogenic amines and their metabolites Biochemical Pharmacology. 21: 1289-1297. PMID 5038674 DOI: 10.1016/0006-2952(72)90290-0  1
1972 Tonge SR, Leonard BE. Partial antagonism of the behavioural and neurochemical effects of phencyclidine by drugs affecting monoamine metabolism Psychopharmacologia. 24: 516-520. PMID 5034506 DOI: 10.1007/BF00423442  1
1972 Leonard BE. 'hallucinogenic drugs and central transmitter substances' International Journal of Neuroscience. 4: 35-43. PMID 4348844 DOI: 10.3109/00207457209147164  1
1972 Leonard BE. The effect of some synthetic analogues of ACTH on the metabolism of biogenic amines in the rat brain British Journal of Pharmacology. 46. PMID 4348184  1
1972 Leonard BE. Effect of phentolamine on the increase in brain glycolysis following the intraventricular administration of dibutyryl-3,5-cyclic adenosine monophosphate and sodium fluoride to mice Biochemical Pharmacology. 21: 115-117. PMID 4333694 DOI: 10.1016/0006-2952(72)90257-2  1
1971 Leonard BE. The effect of some β-adrenergic blocking and other drugs on brain lactate levels following electroshock Neuropharmacology. 10: 517-520. PMID 5094312 DOI: 10.1016/0028-3908(71)90080-3  1
1971 Leonard BE. The effect of some β-adrenergic receptor blocking drugs on carbohydrate metabolism in mouse brain Neuropharmacology. 10: 127-144. PMID 4398445 DOI: 10.1016/0028-3908(71)90034-7  1
1971 Leonard BE. Some effects of butoxamine on glycolysis in the mouse brain Journal of Pharmacy and Pharmacology. 23: 543-544. PMID 4397458  1
1971 Leonard BE. The effect of Δ1,6 tetrahydrocannabinol on biogenic amines and their amino acid precursors in the rat brain Pharmacological Research Communications. 3: 139-145. DOI: 10.1016/0031-6989(71)90045-2  1
1970 Leonard BE, Riddell D. Neurochemical effects of a coma-producing material from mammalian brain Neuropharmacology. 9: 489-502. PMID 5477434 DOI: 10.1016/0028-3908(70)90022-5  1
1970 Leonard BE, Wiseman BD. The effect of ethanol and amphetamine mixtures on the activity of rats in a Y-maze Journal of Pharmacy and Pharmacology. 22: 967-968. PMID 4395532  1
1969 Tonge SR, Leonard BE. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain Life Sciences. 8: 805-814. PMID 5807313  1
1969 Leonard BE. The effect of sodium barbitone, alone and together with acth and amphetamine, on the behaviour of the rat in the multiple "T" maze Neuropharmacology. 8: 427-435. PMID 4310130  1
1968 Leonard BE. The effect of chronic administration of sodium barbitone on chemically and electrically induced convulsions in the rat Neuropharmacology. 7: 463-468. PMID 5712408  1
1968 Leonard BE. The effect of the chronic administration of sodium barbitone on the exploratory behaviour of rats Journal of Pharmacy and Pharmacology. 20: 397-398. PMID 4385448  1
1967 Leonard BE. The effect of chronic administration of barbitone sodium on the behaviour of the rat Neuropharmacology. 6: 63-70. PMID 6031624  1
1966 Leonard BE. The effect of the chronic administration of barbitone sodium on labile compounds in the rat brain Biochemical Pharmacology. 15: 255-262. PMID 5950020  1
1966 Leonard BE. The effect of the chronic administration of barbitone sodium on pituitary-adrenal function in the rat Biochemical Pharmacology. 15: 263-268. PMID 4287846  1
1965 Leonard BE. The effect of audiogenic seizures on labile nitrogen and phosphorus containing compounds in the rat brain Biochemical Pharmacology. 14: 1293-1298. PMID 5857533  1
Show low-probability matches.